(The following is a reformatted version of a press release
issued by the Office of Attorney General Buddy Caldwell
and received via electronic mail. The release was confirmed by
the sender.) 
October 24, 2012 
Attorney General Announces $18.6 Million in New Settlements
with Drug Companies Charged with Fraud 
(BATON ROUGE, LA)--In the state’s ongoing drug price-related
litigation, five pharmaceutical companies will pay Louisiana in
excess of $18.6 million for misreporting drug price information
to Louisiana’s Medicaid program, announced Attorney General
Buddy Caldwell. 
Caldwell said that the fraudulent over-pricing and marketing of
prescription drugs has caused the Louisiana Medicaid program to
grossly over-pay for various drug prescriptions. 
“This office has already recovered millions of Medicaid dollars,
and millions more will be recovered,” said Attorney General
Caldwell.  “We want drug companies who do business with the
state’s Medicaid program to know that we will hold them
accountable for their actions.” 
Caldwell has made it a priority to aggressively pursue the
recovery of taxpayer-funded Medicaid program dollars.  Through
various court challenges, he has recovered more than $194
million since taking office in 2008. 
“We’ve taken significant steps to improve the integrity of our
Medicaid pharmacy program, including a move away from such
fraudulently inflated drug price schedules,” said DHH Secretary
Bruce D. Greenstein. “We will continue our collaboration with
the Attorney General to protect the integrity of our program, so
that providers are reimbursed fairly for the services they
provide, Medicaid recipients receive the prescriptions they
need, and taxpayers know that their dollars are properly spent.” 
Listed below are the five companies who will pay the state of
Louisiana a combined total of $18,683,000 million: 
Bristol Myers Squibb          $  7,200,000
Mylan                         $  5,000,000
Hoffman-LaRoche               $  4,083,000
Novo Nordisk Pharmaceuticals  $  1,400,000
Shionogi, Inc                 $  1,000,000
TOTAL                         $18,683,000 
Since February 2012, the Attorney General’s Office has obtained
$83.8 million in this ongoing drug price-related litigation from
18 defendant pharmaceutical companies, including the five
announced today. 
The proceeds recovered in this litigation will be returned to
Louisiana’s Medicaid program. 
Amanda P. Larkins
(bjh) NY 
Press spacebar to pause and continue. Press esc to stop.